Home LiteratureArticle Details
PMID: 9276736 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.

The Journal of clinical investigation ·Vol. 100 ·No. 5 ·1997-09-01 ·Pages 1193-8

Head CA, Brugnara C, Martinez-Ruiz R, Kacmarek RM, Bridges KR, Kuter D, Bloch KD, Zapol WM

Abstract

The hallmark of sickle cell disease (SCD) is the polymerization of deoxygenated sickle hemoglobin (HbS). In SCD patients, one strategy to reduce red blood cell (RBC) sickling is to increase HbS oxygen affinity. Our objective was to determine if low concentrations of nitric oxide (NO) gas would augment the oxygen affinity of RBCs containing homozygous HbS (SS). Blood containing normal adult hemoglobin (AA) or SS RBCs was incubated in vitro in the presence of varying concentrations of NO up to 80 ppm, and oxygen dissociation curves (ODCs) were measured. In addition, blood was obtained from three AA and nine SS volunteers, before and after breathing 80 ppm NO in air for 45 min, and the ODCs were measured. Exposure of SS RBCs to 80 ppm NO in vitro for 5 min or longer decreased the partial pressure of oxygen at which hemoglobin is 50% saturated with oxygen (P50), an average of 15% (4.8+/-1.7 mmHg mean+/-SE; P < 0.001). The increase in SS RBC oxygen affinity correlated with the NO concentration. The P50 of AA RBCs was unchanged (P > 0.1) by 80 ppm NO. In SS volunteers breathing 80 ppm NO for 45 min, the P50 decreased (P < 0.001) by 4.6+/-2.0 mmHg. 60 min after NO breathing was discontinued, the RBC P50 remained decreased in five of seven volunteers in whom the ODC was measured. There was no RBC P50 change (P > 0.1) in AA volunteers breathing NO. Methemoglobin (Mhb) remained low in all subjects breathing NO (SS Mhb 1.4+/-0.5%), and there was no correlation (r = 0.02) between the reduction in P50 and the change in Mhb. Thus, low concentrations of NO augment the oxygen affinity of sickle erythrocytes in vitro and in vivo without significant Mhb production. These results suggest that low concentrations of NO gas may offer an attractive new therapeutic model for the treatment of SCD.

MeSH Terms
Adolescent Adult Anemia, Sickle Cell/blood,drug therapy Erythrocytes/metabolism Female Humans Male Nitric Oxide/pharmacology,therapeutic use Oxygen/metabolism
Chemicals
Nitric Oxide Oxygen
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Head C A
Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, Massachusetts 02115, USA. head@etherdome.mgh.harvard.edu
Brugnara C
Martinez-Ruiz R
Kacmarek R M
Bridges K R
Kuter D
Bloch K D
Zapol W M
References (29)
29 references, click to expand
  1. Oxygen affinity as an index of hemoglobin S polymerization: a new micromethod.
    Anal Biochem. 1978 Aug 15;89(1):162-73 PMID: 30335
  2. Cooperativity in the dissociation of nitric oxide from hemoglobin.
    J Biol Chem. 1976 May 10;251(9):2788-94 PMID: 1262343
  3. Deoxygenated sickle hemoglobin. Modulation of its solubility by 2,3-diphosphoglycerate and other allosteric polyanions.
    J Biol Chem. 1985 Nov 15;260(26):13897-900 PMID: 4055763
  4. Covalent binding of glutathione to hemoglobin. I. Inhibition of hemoglobin S polymerization.
    J Biol Chem. 1986 Nov 5;261(31):14704-9 PMID: 3771547
  5. Covalent binding of glutathione to hemoglobin. II. Functional consequences and structural changes reflected in NMR spectra.
    J Biol Chem. 1986 Nov 5;261(31):14710-6 PMID: 3771548
  6. Effect of nitric oxide on the oxygen transport of human erythrocytes.
    J Toxicol Environ Health. 1977 May;2(5):1109-13 PMID: 864782
  7. Requirement for therapeutic inhibition of sickle haemoglobin gelation.
    Nature. 1978 Sep 21;275(5677):238-40 PMID: 692700
  8. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.
    N Engl J Med. 1997 Feb 27;336(9):605-10 PMID: 9032045
  9. The effect of methemoglobin formation in sickle cell disease.
    J Clin Invest. 1961 Oct;40:1856-71 PMID: 13868720
  10. Hb Okazaki [beta 93(F8) Cys----Arg], a new hemoglobin variant with increased oxygen affinity and instability.
    FEBS Lett. 1984 Jul 23;173(1):45-7 PMID: 6745435
  11. Gelation of sickle hemoglobin. III. Nitrosyl hemoglobin.
    J Mol Biol. 1975 Aug 25;96(4):733-43 PMID: 509
  12. Reaction of nitric oxide with heme proteins and model compounds of hemoglobin.
    Biochemistry. 1987 Jun 30;26(13):3837-43 PMID: 3651417
  13. Hemoglobin S gelation and sickle cell disease.
    Blood. 1987 Nov;70(5):1245-66 PMID: 3311198
  14. Intracellular polymerization. Disease severity and therapeutic predictions.
    Ann N Y Acad Sci. 1989;565:75-82 PMID: 2476066
  15. Sickle cell hemoglobin polymerization.
    Adv Protein Chem. 1990;40:63-279 PMID: 2195851
  16. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.
    Circulation. 1991 Jun;83(6):2038-47 PMID: 2040056
  17. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.
    Lancet. 1991 Nov 9;338(8776):1173-4 PMID: 1682593
  18. Nitric oxide can modify amino acid residues in proteins.
    Biochem Biophys Res Commun. 1992 Mar 16;183(2):598-604 PMID: 1550567
  19. Inhaled nitric oxide for the adult respiratory distress syndrome.
    N Engl J Med. 1993 Feb 11;328(6):399-405 PMID: 8357359
  20. Nitric oxide and the lung.
    Am J Respir Crit Care Med. 1994 May;149(5):1375-80 PMID: 8173780
  21. Sickle cell disease of transgenic SAD mice.
    Blood. 1994 Nov 1;84(9):3189-97 PMID: 7949191
  22. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    N Engl J Med. 1995 May 18;332(20):1317-22 PMID: 7715639
  23. Antisickling effects of 2,3-diphosphoglycerate depletion.
    Blood. 1995 Jun 1;85(11):3289-96 PMID: 7756662
  24. Performance characteristics of Hemox-Analyzer for assessment of the hemoglobin dissociation curve.
    Haematologica. 1995 Sep-Oct;80(5):426-30 PMID: 8566883
  25. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control.
    Nature. 1996 Mar 21;380(6571):221-6 PMID: 8637569
  26. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.
    J Clin Invest. 1996 Mar 1;97(5):1227-34 PMID: 8636434
  27. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia.
    J Clin Invest. 1972 Mar;51(3):566-74 PMID: 5011101
  28. Gelation of sickle cell haemoglobin. II. Methaemoglobin.
    J Mol Biol. 1974 Nov 15;89(4):759-66 PMID: 4449131
  29. The effect of carbon monoxide on red cell life span in sickle cell disease.
    Blood. 1975 Aug;46(2):253-9 PMID: 237591
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1997-09-01
Pages
1193-8
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC508295
Subset
IM
Grants
NHLBI NIH HHS · HL-15157 · United States
NHLBI NIH HHS · HL-42397 · United States
NHLBI NIH HHS · HL-55377 · United States
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com